Upcoming Allied Market Research
Lassa Virus Market

Lassa Virus Market

by Treatment (Ribavirin Tablets, Ribavirin Inhalation Solution, and Ribavirin Oral Solution), Diagnosis (Enzyme-Linked Immunosorbent Serologic Assays and Reverse Transcription-Polymerase Chain Reaction), and End User (Hospitals, Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A14035
Pages: NA
Nov 2022 | 541 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Lassa Virus Market

Request Now !

Lassa virus, also known as the Lassa mammarenavirus (LASV), is the arenavirus known to cause Lassa hemorrhagic fever in humans and other primates. Lassa virus requires biosafety level-equivalent containments. It is an endemic in many West African countries such as the Republic of Guinea, Liberia, Nigeria, and Sierra Leona, where the annual number of Lassa viral fever cases is between 300,000 and 500,000, resulting in the annual death of 5,000 infected patients. The spread of the disease is linked to the village of Lassa in Nigeria where a missionary nurse first contracted it in 1969. In humans, the Lassa virus is spread through contact with infected Mastomyl natalensis, the multimammate rat.

COVID-19 Impact Analysis

  • COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020. 
  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19. 
  • However, with COVID-19, the supply chain of the raw materials required to manufacture drugs for the Lassa virus has been disrupted in many countries. In addition, the market growth of pharmaceuticals is declining as the manufacturers of drugs have slowed down their production because of the pandemic. This, in turn, is expected to have a significant impact on the Lassa virus market. 

Top Impacting Factors
Rising prevalence of Lassa fever in many developing economies and low-income countries is fuelling the growth of the Lassa virus market. 
Growing population of Mastomys rats all over the world is another factor contributing to the growth of the Lassa virus market. Humans often become infected with the Lassa virus when they come in contact with the feces or urine of infected Mastomys rats. 
Lassa virus is commonly widespread in some areas of Sierra Leone and Liberia; however, international travels from such regions to all corners of the world have increased the chances of the spreading of the virus. This factor is further contributing to the growth of the Lassa virus market.
However, the difficulty to diagnose the Lassa virus based on a patient's clinical presentation and the dearth of skilled healthcare professionals in low-income countries are some of the factors that are impeding the growth of the Lassa virus market. 
Key Market Trends

  • The global Lassa virus market is expected to witness a boost during the forecast period especially in the region of West Africa, owing to the emergence of 100,000 to 300,000 cases of Lassa fever each year.
  • According to the World Health Organization (WHO), around 10–15% of people who have Lassa viral fever belong to the areas of Liberia and Sierra Leone.
  • Key pharmaceutical companies of the Lassa virus market are focused on research and development activities regarding the development of vaccines and diagnostic tests for the Lassa virus.
  • Promising growth in revenue in the Lassa virus market is expected during the forecast period, as various key players of the market are set to launch novel Lassa viral fever treatment products.
  • West Africa dominates the Lassa virus market, due to the presence of large patient pool prone to get infected with the virus and the increasing incidence of the disease in people from all age groups in the Middle East and Africa. 

Key Benefits of the Report

  • This study presents the analytical depiction of the Lassa virus industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the Lassa virus market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
  • Questions Answered in the Lassa Virus Report
  • Which are the leading players active in the Lassa virus market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the Lassa virus in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
  • What are the impacts of COVID-19 on the industry?
  • What is the Lassa virus?
  • What are the current and predicted trends of the market?

Lassa Virus Market Report Highlights

Aspects Details
By Treatment
  • Ribavirin Tablets
  • Ribavirin Inhalation Solution
  • Ribavirin Oral Solution
By Diagnosis
  • Enzyme-Linked Immunosorbent Serologic Assays (ELISA)
  • Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
By End User
  • Hospitals
  • Clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Zydus Pharmaceuticals, Valeant pharmaceuticals international, F. Hoffmann La Roche AG, Sandoz Inc. (Novartis AG), Teva Pharmaceuticals, Three Rivers Pharmaceuticals LLC, Schering-Plough Research Institute

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Lassa Virus Market

Start reading.
This Report and over 19,266+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers